To identify reliable markers of LRRK2 activity in human CSF.
Not Recruiting
30-99 years
All
Phase
N/A
30 participants needed
1 Location
Brief description of study
The purpose of this research study is to evaluate new tests for Parkinson's disease (PD) that may help in developing better treatments.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Parkinsons
-
Age: Between 30 Years - 99 Years
-
Gender: All
- Conditions: Parkinsons
- Age: Between 30 - 99 Years
- Gender: Male or Female
Updated on
10 May 2024.
Study ID: 844136
